Patents by Inventor Douglas Lytle Mayers

Douglas Lytle Mayers has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170066795
    Abstract: Provided herein are compounds, compositions and methods for the treatment of Flaviviridae infections, including HCV infections. In certain embodiments, compounds and compositions of nucleoside derivatives are disclosed, which can be administered either alone or in combination with other anti-viral agents.
    Type: Application
    Filed: March 5, 2015
    Publication date: March 9, 2017
    Applicants: IDENIX PHARMACEUTICALS LLC, Merck Sharp & Dohme Corp.
    Inventors: John Zoltan Sulliva-Bolyai, Benjamin Alexander Mayes, Douglas Lytle Mayers, Xiao-Jian Zhou, Adel M. Moussa, Alistair James Stewart, Sindhura Ganga, Clinton Scott Shultz, Alfred Lee
  • Publication number: 20080139495
    Abstract: In accordance with the present invention there is provided a pharmaceutical composition useful for the treatment or prophylaxis of viral infections comprising a compound of the formula (I) and at least one antiviral active compound of the formula (II) wherein Base is selected from the group consisting of thymine, cytosine, adenine, guanine, inosine, uracil, 5-ethyluracil and 2,6-diaminopurine.
    Type: Application
    Filed: January 25, 2008
    Publication date: June 12, 2008
    Inventors: Heinz-Gerd Klaes, Elena Koundourakis, Hernan Valdez, Douglas Lytle Mayers
  • Patent number: 7244716
    Abstract: In accordance with the present invention there is provided a pharmaceutical composition useful for the treatment or prophylaxis of viral infections comprising tipranavir and at least one antiviral active compound of formula (I) wherein Base is selected from the group consisting of thymine, cytosine, adenine, guanine, inosine, uracil, 5-ethyluracil and 2,6-diaminopurine, or a pharmaceutically acceptable salt or prodrug thereof.
    Type: Grant
    Filed: March 25, 2004
    Date of Patent: July 17, 2007
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Heinz-Gerd Klaes, Elena Koundourakis, Hernan Valdez, Douglas Lytle Mayers
  • Publication number: 20040235779
    Abstract: In accordance with the present invention there is provided a pharmaceutical composition useful for the treatment or prophylaxis of viral infections comprising tipranavir and at least one antiviral active compound of formula (I) 1
    Type: Application
    Filed: March 25, 2004
    Publication date: November 25, 2004
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Heinz-Gerd Klaes, Elena Koundourakis, Hernan Valdez, Douglas Lytle Mayers
  • Publication number: 20040235780
    Abstract: In accordance with the present invention there is provided a pharmaceutical composition useful for the treatment or prophylaxis of viral infections comprising nevirapine and at least one antiviral active compound of formula (I) 1
    Type: Application
    Filed: March 25, 2004
    Publication date: November 25, 2004
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Heinz-Gerd Klaes, Elena Koundourakis, Hernan Valdez, Douglas Lytle Mayers
  • Publication number: 20040235781
    Abstract: In accordance with the present invention there is provided a pharmaceutical composition useful for the treatment or prophylaxis of viral infections comprising a compound of the formula (I) 1
    Type: Application
    Filed: March 25, 2004
    Publication date: November 25, 2004
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Heinz-Gerd Klaes, Elena Koundourakis, Hernan Valdez, Douglas Lytle Mayers